These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Combating resistance: application of the emerging science of pharmacokinetics and pharmacodynamics. Jacobs MR Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S122-6. PubMed ID: 17936592 [TBL] [Abstract][Full Text] [Related]
23. Susceptibility of multiresistant serotype 012 Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics. Watine J; Bourrel C; Dubourdieu B; Gineston JL; Bories P; Durand M; Marre A; Formosa F; Brunel MP; Palliez J Pathol Biol (Paris); 1994 Apr; 42(4):293-5. PubMed ID: 7808781 [TBL] [Abstract][Full Text] [Related]
24. Infection control series: III. Clinical application of aminoglycoside drug levels. Leonard RF W V Med J; 1981 May; 77(5):105-10. PubMed ID: 6243027 [No Abstract] [Full Text] [Related]
25. Pharmacodynamic properties of antibiotics: application to drug monitoring and dosage regimen design. Ebert SC; Craig WA Infect Control Hosp Epidemiol; 1990 Jun; 11(6):319-26. PubMed ID: 2165081 [No Abstract] [Full Text] [Related]
26. [Antimicrobial therapy]. Di Nola F; Soranzo ML Minerva Med; 1985 Jan; 76(1-2):1-13. PubMed ID: 3883239 [TBL] [Abstract][Full Text] [Related]
33. Influence of pharmacokinetics/pharmacodynamics of antibacterials in their dosing regimen selection. Scaglione F; Paraboni L Expert Rev Anti Infect Ther; 2006 Jun; 4(3):479-90. PubMed ID: 16771624 [TBL] [Abstract][Full Text] [Related]
35. Role of pharmacokinetics and pharmacodynamics: does the dose matter? MacGowan AP Clin Infect Dis; 2001 Sep; 33 Suppl 3():S238-9. PubMed ID: 11524725 [TBL] [Abstract][Full Text] [Related]
36. [Pharmacokinetics of antibiotics in burn patients]. Lesne-Hulin A; Bourget P; Carsin H Therapie; 1995; 50(6):575-86. PubMed ID: 8745959 [TBL] [Abstract][Full Text] [Related]
37. Development of the quinolones. Andersson MI; MacGowan AP J Antimicrob Chemother; 2003 May; 51 Suppl 1():1-11. PubMed ID: 12702698 [TBL] [Abstract][Full Text] [Related]
38. Aminoglycosides are useful for severe respiratory tract infections. Craig WA; Andes D Semin Respir Infect; 1997 Dec; 12(4):271-7. PubMed ID: 9436954 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic/pharmacodynamic evaluation of anti-infective agents. Schuck EL; Derendorf H Expert Rev Anti Infect Ther; 2005 Jun; 3(3):361-73. PubMed ID: 15954853 [TBL] [Abstract][Full Text] [Related]
40. [Pharmacokinetic and pharmacodynamic bases of empirical antibiotic therapy]. Bourgoin A; Martin C Ann Fr Anesth Reanim; 2004 Jun; 23(6):626-30. PubMed ID: 15234732 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]